New hope for Tough-to-Treat colon cancer: experimental drug combo enters final testing

NCT ID NCT07549412

First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This Phase 3 trial tests a new drug called precemtabart tocentecan, alone or with bevacizumab, against a standard treatment for metastatic colorectal cancer that has progressed after prior therapies. About 1,020 participants will be randomly assigned to one of three treatment groups. The main goal is to see if the new drug helps people live longer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
precemtabart tocentecan (a drug), bevacizumab, and trifluridine/tipiracil
What this could lead to
If successful, this could offer a new treatment option for people with metastatic colorectal cancer who have already tried standard therapies, potentially extending survival.
What could go wrong
This is a large Phase 3 trial, but the experimental drug is still unproven. It may not improve survival or could cause side effects. Results may take years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Blue Ridge Cancer Care - 300202915

    RECRUITING

    Roanoke, Virginia, 24014-2419, United States

  • Cancer Institute Hospital of JFCR

    RECRUITING

    Kōtoku, Tokyo-To, 135-8550, Japan

  • China Medical University Hospital

    RECRUITING

    Taichung, 40447, Taiwan

  • Flinders Medical Centre

    RECRUITING

    Bedford Park, South Australia, 5042, Australia

  • Florida Cancer Specialists - St. Petersburg Bayfront

    RECRUITING

    St. Petersburg, Florida, 33701-4553, United States

  • Florida Cancer Specialists East - FCS EAST - West Palm Beach

    RECRUITING

    West Palm Beach, Florida, 33401, United States

  • Florida Cancer Specialists-Broadway

    RECRUITING

    Fort Myers, Florida, 33901, United States

  • GenesisCare North Shore (Oncology)

    RECRUITING

    St Leonards, New South Wales, 2065, Australia

  • Icon Cancer Centre Chermside

    RECRUITING

    Chermside, Queensland, 4032, Australia

  • Illinois Cancer Specialists

    RECRUITING

    Arlington Heights, Illinois, 60005, United States

  • Illinois CancerCare PC

    RECRUITING

    Peoria, Illinois, 61615-7822, United States

  • Kanagawa Cancer Center - Dept of Gastroenterology

    RECRUITING

    Yokohama, Kanagawa, 241-8515, Japan

  • Kindai University Hospital

    RECRUITING

    Sakai-shi, Osaka, 590-0197, Japan

  • Kyungpook National University Chilgok Hospital

    RECRUITING

    Daegu, Gyeongsangnam-do, 700-721, South Korea

  • Mater Misericordiae Ltd - PARENT

    RECRUITING

    South Brisbane, Queensland, 4101, Australia

  • Minnesota Oncology Hematology, P.A.

    RECRUITING

    Saint Louis Park, Minnesota, 55416, United States

  • Missouri Cancer Associates - 150518964

    RECRUITING

    Columbia, Missouri, 65201, United States

  • National Cancer Center Hospital

    RECRUITING

    Chūōku, Tokyo-To, 104-0045, Japan

  • Profound Research LLC at Cancer and Leukemia Center

    RECRUITING

    Sterling Heights, Michigan, 48098, United States

  • Rocky Mountain Cancer Centers, LLP- Aurora

    RECRUITING

    Lone Tree, Colorado, 80124, United States

  • SCRI Oncology Partners

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Samsung Medical Center

    RECRUITING

    Seoul, 06351, South Korea

  • Severance Hospital, Yonsei University Health System - Division of Infectious Diseases

    RECRUITING

    Seoul, 03722, South Korea

  • Sichuan Cancer Hospital

    RECRUITING

    Chengdu, Sichuan, 610041, China

  • Springfield Clinic

    RECRUITING

    Springfield, Illinois, 62702, United States

  • Sun Yat-sen University Cancer Center

    RECRUITING

    Guangzhou, Guangdong, 510060, China

  • Texas Oncology DFW

    RECRUITING

    Bedford, Texas, 75246, United States

  • Texas Oncology, P.A. - Abilene - 300210366

    RECRUITING

    Abilene, Texas, 79606, United States

  • Texas Oncology, P.A. - Tyler

    RECRUITING

    Tyler, Texas, 75702, United States

  • Texas Oncology- San Antonio

    RECRUITING

    San Antonio, Texas, 78240, United States

  • Texas Oncology-South Austin

    RECRUITING

    Austin, Texas, 78745, United States

  • The Catholic University of Korea, Seoul St. Maryâ

    RECRUITING

    Seoul, 06591, South Korea

  • University Health Network - Princess Margaret Cancer Centre

    RECRUITING

    Toronto, Ontario, M5G 2M9, Canada

  • Virginia Oncology Associates

    RECRUITING

    Newport News, Virginia, 23606, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.